Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAPGEF4 | Q8WZA2 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.34 |
| ▸ | MAPT | P10636 | 3/20 | 0.34 |
| ▸ | GAA | P10253 | 2/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | GLA | P06280 | 1/20 | 0.33 |
| ▸ | ACHE | P22303 | 2/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | APEX1 | P27695 | 1/20 | 0.31 |
| ▸ | MPI | P34949 | 1/20 | 0.31 |
| ▸ | RECQL | P46063 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | MMP1 | P03956 | 1/20 | 0.31 |
| ▸ | MMP2 | P08253 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12123548 | 0.79 | PTPN1 (0.43) | ALDH1A1PTPN1KMT2APOLBCA1 | |
| SCHEMBL448144 | 0.79 | RAPGEF4 (0.38) | RAPGEF4ALDH1A1KDM4EMAPTGAA | |
| SCHEMBL3437802 | 0.75 | ALDH1A1 (0.42) | ALDH1A1KDM4ELMNAACHECA1 | |
| SCHEMBL28221317 | 0.73 | ALDH1A1 (0.40) | ALDH1A1KDM4ELMNAACHECA1 | |
| SCHEMBL12930400 | 0.72 | ALDH1A1 (0.41) | ALDH1A1MAPTACHETP53TDP1 | |
| Methyl Alcohol SCHEMBL28790286 | 0.70 | ALDH1A1 (0.39) | RAPGEF4ALDH1A1KDM4EMAPTGAA | |
| SCHEMBL15364372 | 0.70 | RAPGEF4 (0.39) | RAPGEF4ALDH1A1KDM4EMAPTGAA | |
| SCHEMBL11420240 | 0.69 | RAPGEF4 (0.43) | RAPGEF4ALDH1A1KDM4EMAPTGAA | |
| SCHEMBL242786 | 0.69 | RAPGEF4 (0.43) | RAPGEF4ALDH1A1KDM4EMAPTGAA | |
| SCHEMBL25899346 | 0.69 | FFAR1 (0.34) | RAPGEF4ALDH1A1MAPTKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11844229-B2 | Electroluminescent element, and light emitting device, display device and lighting device each using organic electroluminescent element | UDC IRELAND LIMITED (IE) | 2023-12-12 | — | — | US | disclosed |
| US-8822043-B2 | Organic compound and organic light-emitting device | CANON KABUSHIKI KAISHA (JP) | 2014-09-02 | — | — | US | disclosed |
| US-20140203252-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, AND LIGTH EMITTING DEVICE, DISPLAY DEVICE AND LIGHTING DEVICE EACH USING ORGANIC ELECTROLUMINESCENT ELEMENT | UDC IRELAND LIMITED (IE) | 2014-07-24 | — | — | US | disclosed |
| US-20120091450-A1 | NOVEL ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE | CANON KABUSHIKI KAISHA (JP) | 2012-04-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11844229-B2 | Electroluminescent element, and light emitting device, display device and lighting device each using organic electroluminescent element | LAS1L, CCNL2, CDC5L | RAPGEF4 3322/4885ALDH1A1 939/4885KDM4E 888/4885 |
| US-20120091450-A1 | NOVEL ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE | TRPA1, AFF4, TYR | RAPGEF4 1969/4885ALDH1A1 189/4885KDM4E 1988/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.